Foghorn Stock Sinks as Lilly Scraps Cancer Deal, Forcing 40% Layoffs
Foghorn Therapeutics and Eli Lilly don’t plan any future collaborations following the dissolution of a cancer-drug partnership.
Foghorn Therapeutics and Eli Lilly don’t plan any future collaborations following the dissolution of a cancer-drug partnership.